Key facts
- Leaflet Solutions’s last known valuation is $4.2M (Jul 2025).
- It has raised $4.2M; the latest was Seed Round ($4.2M) in Jul 2025.
- Notable investors include Front Row Ventures, Campus des technologies de la santé, Glen Ventures, Innovation and Energy, Quebec Ministry of Economy — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Leaflet Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Leaflet Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Leaflet Solutions
Developer of a heart valve treatment device intended to serve patients suffering from moderate to severe heart valve diseases. The company's platform incorporates a minimally invasive catheter system capable of precisely altering the anterior mitral valve leaflet to prevent obstruction during valve implantation, enabling interventional cardiologists and cardiac surgeons to treat patients with mitral regurgitation who are otherwise ineligible for transcatheter valve replacement, and providing a safer, more accessible alternative to open-heart surgery.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2024
- Employees
- 5
- Website
- leaflet-solutions.com/
- Ownership
- Privately Held (backing)
Leaflet Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Leaflet Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Leaflet Solutions in its N-PORT filings yet. We sweep new filings monthly.